MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are a group of small noncoding RNA molecules, 18–25 nucleotides in length, which can negatively regulate gene expression at the post‐transcriptional level by binding to messenger RNAs. About half of all identified miRNAs in humans are expressed in the brain and display regulatory functions important for many biological processes related to the development of the central nervous system (CNS). Disruptions in miRNA biogenesis and miRNA‐target interaction have been related to CNS diseases, including psychiatric disorders. In this review, we focus on the role of miRNAs in autism spectrum disorder (ASD) and summarize recent findings about ASD‐associated genetic variants in miRNA genes, in miRNA biogenesis genes, and miRNA targets. We discuss deregulation of miRNA expression in ASD and functional validation of ASD‐related miRNAs in animal models. Including miRNAs in studies of ASD will contribute to our understanding of its etiology and pathogenesis and facilitate the discrimination between different disease subgroups. Autism Res 2017. © 2017 International Society for Autism Research, Wiley Periodicals, Inc. Autism Res 2017, 10: 1184–1203. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A reference panel of 64,976 haplotypes for genotype imputation
the Haplotype Reference Consortium (2016) · Nature Genetics · doi:10.1038/ng.3643 · Cited by 2,836
Synaptic, transcriptional and chromatin genes disrupted in autism
Study, T. D., De Rubeis, S., Autism, H. M. C. F., UK10K Consortium, The Autism Sequencing Consortium, He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Ercument Cicek, A., et al. (2014) · Nature · doi:10.1038/nature13772 · Cited by 2,746
The contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585 · cited 9×
“As for identification of de novo variation, trio-sequencing of both parents and their offspring could be performed using WES or WGS [De Rubeis et al., 2014; Iossifov et al., 2014], although with WES only protein-coding regions are sequenced prohibiting assessment of the burden of de novo variants in miRNA genes and mi…”
MethodInfluentialGenetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263
MicroRNA profiling: approaches and considerations
Pritchard, C. C., Cheng, H. H., & Tewari, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3198 · Cited by 1,765
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375 · cited 1×
“Induced pluripotent stem cells (iPSCs), are stem cells induced from patient tissues and iPSC technology has been used to model neurodevelopmental disorders [Brennand et al., 2011; Zhao et al., 2015].”
MethodClop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Most genetic risk for autism resides with common variation
Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., Mahajan, M., Manaa, D., Pawitan, Y., Reichert, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.3039 · Cited by 1,239 · cited 2×
“to contribute to nearly half of the variation in the risk for ASD [Gaugler et al., 2014].”
BackgroundStudy, L. C., Okbay, A., Baselmans, B. M. L., De Neve, J.-E., Turley, P., Nivard, M. G., Fontana, M. A., Meddens, S. F. W., Linnér, R. K., Rietveld, C. A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3552 · Cited by 1,013 · cited 1×
“…association studies (GWASs) have shown that a number of common genetic variants contribute, albeit to a small extent, to the genetic risk for psychiatric disorders like schizophrenia [Ripke et al., 2014], bipolar disorder [Hou et al., 2016], or symptoms of depression [Okbay et al., 2016].”
BackgroundSelf-citationEvolution of microRNA diversity and regulation in animals
Berezikov, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3079 · Cited by 712 · cited 3×
“One happened at the time when bilaterian species (animals with bilateral symmetry) appeared and the other happened at the time when vertebrates appeared [Berezikov, 2011].”
BackgroundExcess of rare, inherited truncating mutations in autism
Krumm, N., Turner, T. N., Baker, C., Vives, L., Mohajeri, K., Witherspoon, K., Raja, A., Coe, B. P., Stessman, H. A., He, Z.-X., et al. (2015) · Nature Genetics · doi:10.1038/ng.3303 · Cited by 587
MicroRNA history: Discovery, recent applications, and next frontiers
Almeida, M. I., Reis, R. M., & Calin, G. A. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.009 · Cited by 466
Genomewide Association Studies: History, Rationale, and Prospects for Psychiatric Disorders
Psychiatric GWAS Consortium Coordinating Committee (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08091354 · Cited by 450
Miller, D. T., Shen, Y., Weiss, L. A., Korn, J., Anselm, I., Bridgemohan, C., Cox, G. F., Dickinson, H., Gentile, J., Harris, D. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059907 · Cited by 427 · cited 1×
“2 deletion [De Rubeis & Buxbaum, 2015; Fett-Conte et al., 2015], which disrupt a miRNA gene (MIR211) and an important miRNA biogenesis gene (DGCR8) respectively [Alural et al., 2017; Miller et al., 2009].”
BackgroundThe role of de novo mutations in the genetics of autism spectrum disorders
Ronemus, M., Iossifov, I., Levy, D., & Wigler, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3585 · Cited by 390
Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2
Liu, Z., Li, X., Zhang, J.-T., Cai, Y.-J., Cheng, T.-L., Cheng, C., Wang, Y., Zhang, C.-C., Nie, Y.-H., Chen, Z.-F., et al. (2016) · Nature · doi:10.1038/nature16533 · Cited by 322 · cited 1×
“Another study using an MECP2 transgenic nonhuman primate, demonstrated that overexpression of MECP2 leads to autism-like behaviors and specifically reduced the social interactions in these animals [Liu et al., 2016].”
BackgroundDetermining the role of microRNAs in psychiatric disorders
Issler, O., & Chen, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3879 · Cited by 309
Cheng, T.-L., Wang, Z., Liao, Q., Zhu, Y., Zhou, W.-H., Xu, W., & Qiu, Z. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.01.032 · Cited by 270 · cited 4×
“Loss of function mutations of MECP2 contribute to Rett syndrome while duplication of MECP2 may result in a wide spectrum of disorders, including autism and intellectual disability (ID) [Cheng et al., 2014; Han et al., 2013].”
BackgroundInfluentialLiu, C., Zhang, F., Li, T., Lu, M., Wang, L., Yue, W., & Zhang, D. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-661 · Cited by 264 · cited 1×
“MirSNP is a database that annotates human SNPs in predicted miRNA target sites [Liu et al., 2012; URL: http://bioinfo. bjmu.edu.cn/mirsnp].”
BackgroundAn epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Identification of differentially expressed microRNAs across the developing human brain
Ziats, M. N., & Rennert, O. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.93 · Cited by 214
Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder
Wu, Y. E., Parikshak, N. N., Belgard, T. G., & Geschwind, D. H. (2016) · Nature Neuroscience · doi:10.1038/nn.4373 · Cited by 195
Talebizadeh, Z., Butler, M. G., & Theodoro, M. F. (2008) · Autism Research · doi:10.1002/aur.33 · Cited by 157
Robinson, E. B., Samocha, K. E., Kosmicki, J. A., McGrath, L., Neale, B. M., Perlis, R. H., & Daly, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409204111 · Cited by 142
Experience-dependent expression of miR-132 regulates ocular dominance plasticity
Tognini, P., Putignano, E., Coatti, A., & Pizzorusso, T. (2011) · Nature Neuroscience · doi:10.1038/nn.2920 · Cited by 130
Mor, M., Nardone, S., Sams, D. S., & Elliott, E. (2015) · Molecular Autism · doi:10.1186/s13229-015-0040-1 · Cited by 118
Cited by
TransmiR v2.0: an updated transcription factor-microRNA regulation database
Tong, Z., Cui, Q., Wang, J., & Zhou, Y. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1023 · Cited by 356
“In recent years, abundant evidence has shown that the deregulation of specific miRNA is associated with various diseases like cancers (2,4), cardiovascular diseases (5,6), and psychiatric disorders (7,8).”
BackgroundCurrent Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
Eissa, N., Al-Houqani, M., Sadeq, A., Ojha, S. K., Sasse, A., & Sadek, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00304 · Cited by 260
Blood biomarkers and treatment response in major depression
Mora, C., Zonca, V., Riva, M. A., & Cattaneo, A. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1470927 · Cited by 107
“Their biogenesis in mammals is a step process that involves multiple enzyme (for a detailed review [73]) and they have two key roles in the regulation of messenger RNA (mRNA): they act by inducing either degradation or translational silencing of the mRNA they target, but in certain instances, miRNAs may activate trans…”
BackgroundImmunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy
Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S. (2018) · Neuroimmunomodulation · doi:10.1159/000492225 · Cited by 70
Metadata
- Authors
- Hu, Y., Ehli, E. A., & Boomsma, D. I.
- Venue
- Autism Research
- Publisher
- Wiley
- Published
- 2017-04-17
- Volume
- 10
- Issue
- 7
- Pages
- 1184-1203
- ISSN
- 1939-3792 (ISSN-L)
- 1939-3806
- OpenAlex
- W2606394326
- Cited by
- 50
- References
- 26
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.